Anti-tumor Effects of CV-6504 on Mouse Tumors
Author Information
Author(s): HJ Hussey, MC Bibby, MJ Tisdale
Primary Institution: Pharmaceutical Sciences Institute, Aston University
Hypothesis
Does CV-6504 exhibit anti-tumor activity against established murine adenocarcinomas?
Conclusion
CV-6504 shows significant anti-tumor activity against murine adenocarcinomas, particularly in inhibiting tumor growth and reversing cachexia.
Supporting Evidence
- CV-6504 significantly inhibited tumor growth in MAC16, MAC13, and MAC26 tumors.
- Optimal doses of CV-6504 led to a doubling of time to sacrifice due to cachexia.
- Histological examination showed extensive necrosis in treated tumors.
Takeaway
CV-6504 is a new medicine that helps fight certain types of cancer in mice by stopping tumors from growing and helping the mice feel better.
Methodology
The study involved administering CV-6504 to mice with transplanted MAC tumors and measuring tumor growth and body weight over time.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Male NMRI mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website